Genedata expands global presence to operate in close proximity to new and long-standing customers in the region Singapore Genedata, a leading provider of advanced software solutions for biopharmaceutical and related life science R&D, today announced the establishment of a new Genedata subsidiary, Genedata Pte. Ltd., in Singapore. The creation of the Singaporean subsidiary demonstrates Genedata’s […]
Biolytic introduces the Dr. Oligo 192c – their latest and most advanced synthesizer at a lower price
Fremont, California – December 3, 2018 – Biolytic Lab Performance Inc. is proud to announce their latest high throughput oligo synthesizer, the Dr. Oligo 192c, built on Biolytic’s Molecule Synthesis Platform. Now restructured with all the same principles and key design aspects that have allowed them to become the world’s fastest in oligonucleotide synthesis, the 192c incorporates […]
Tokyo, Japan – Quantum Biosystems Inc. today announced that it has closed a Series C financing round of JPY 1 Billion ($8.9 Million), through the sale of preferred stock to SBI Investment Co., Ltd., a Japanese venture capital company. Details of the financing were not disclosed. Quantum Biosystems is developing a novel, single molecule sequencing […]
(ANN ARBOR, Mich.) Swift Biosciences today announced the availability of its eagerly anticipated Normalase™ Kit, a revolutionary enzymatic library normalization product that streamlines the cumbersome steps following next-generation sequencing (NGS) library preparation. Compared to conventional normalization, Swift Normalase saves cost on sequencing by reducing read depth variation within a pool down to a coefficient of variation […]
On November 26, 2018, China National GeneBank (CNGB) and BGI Research and the Macquarie University of Australia formally signed a cooperation agreement during the 7th International Yeast 2.0 and Synthetic Genomes Conference 2018 in Sydney, Australia. The two sides will jointly promote scientific research and education in synthetic biology, and focus on scientific research cooperation in natural products synthesisand […]
We are unveiling our new Sample to Insight QIAact Myeloid DNA UMI Panel at the American Society of Hematology (ASH) 60th Annual Meeting and Exposition held December 1-4, 2018, in San Diego, California. Stop by booth #1557 at ASH to explore our complete Sample to Insight solution for interrogating 25 genes for variants with known significance to clonal myeloid malignancies. Coupled […]
Genomenon announced that it has published the first Cited Variant Reference (CVR), a comprehensive catalogue of genetic variants cited in the medical literature. The term “variant” refers to a genomic mutation in the DNA – key data used in searching for causes of cancer and rare diseases. This first-in-kind Cited Variant Reference contains over 3.7 million […]
SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more than 25 years of executive and financial leadership experience […]
Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories. SeraCare provides quality control materials for infectious disease testing through their ACCURUN® reagents as well as in the fast growing clinical next-generation sequencing (NGS) market which it addresses through its Seraseq® brand of […]
Chicago, IL – Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, announced the sale of SeraCare Life Sciences (“SeraCare” or the “Company”) to LGC North America Inc. (“LGC”), a portfolio company of KKR & Co. Inc. SeraCare, a portfolio company of Linden Capital Partners, is a developer and manufacturer of biological products used […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
